title: Personalized medicine for breast cancer: it is a new day!
abstract: Breast cancer remains the most common cancer diagnosed in women in the United States and is second only to lung cancer as a cause of cancer mortality. Breast cancer has become the prototypical solid tumor where targets have been identified within the tumor allowing for a personalized approach of systemic therapy.
authors.affiliation: Department of Medicine, University of Southern California, 1441 Eastlake Avenue, Room 3448, Los Angeles, CA 90033, USA. Electronic address: christy.russell@med.usc.edu.
authors.forename: Christy A
authors.initials: CA
authors.lastname: Russell
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics / Q000378:metabolism / Q000628:therapy*; D005260:Female; D006801:Humans; D009154:Mutation; D057285:Precision Medicine; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000096:biosynthesis; D011960:Receptors, Estrogen / Q000096:biosynthesis; D011980:Receptors, Progesterone / Q000096:biosynthesis
chemical_list: D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone
keywords: Breast cancer; Estrogen receptor; HER2 positive breast cancer; Personalized medicine; Triple negative breast cancer